Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial - CNN
- Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial CNN
- For Alzheimer’s patients, this Novo Nordisk GLP-1 drug slows cognitive decline, study finds MarketWatch
- Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says CNBC
- GLP-1 for dementia, Alzheimer's: early study looks promising Business Insider